willdate
Pulmonary artery denervation shows promise in pulmonary hypertension linked to heart-failure
Patients with pulmona...
ESC 2026: DOACs only prevent leaflet thickening in the short term after TAVI
Three months of direc...
PREMIUM trial results not supportive of prasugrel monotherapy at the time of PCI for STEMI
Low-dose prasugrel mo...
IMDS launches microcatheter designed to improve lesion crossing in challenging anatomy
Interventional Medica...
Medtronic’s Endurant stent graft system receives CE mark for updated rupture labelling
Medtronic has receive...
AI cardiovascular diagnostic specialist Elucid completes latest financing round
Elucid has raised US$...
ESC 2026: Clopidogrel monotherapy non-inferior to extended DAPT in patients at high ischaemic risk
Clopidogrel monothera...
ESC 2026: Trial results do not support routine LAA closure in all patients undergoing planned cardiac surgery
Routine concomitant closu...
GE HealthCare gains CE marking for Photonova Spectra photon-counting CT system
GE HealthCare has achieve...
ESC 2026: Tricuspid repair comes out on top versus medical therapy in trial among high-risk patients
Transcatheter tricusp...
First US commercial cases performed using Protaryx transseptal puncture device
Protaryx Medical has ...
ESC 2026: Simplified definition of MI aims to improve diagnosis and treatment
A universal definition of...
Heart Valve Voice highlights opportunities to streamline valve disease care
A new report from the UK ...
Study highlights challenges in using AI-ECG detection to screen for structural heart disease
Artificial intelligen...
Mohamad Alkhouli named editor-in-chief of JACC: Cardiovascular Interventions
The American College ...
Iron transfusion prior to cardiac surgery reduces the need for blood in anaemic patients
Giving intravenous iron t...
Cold-stored platelets may expand options for addressing bleeding during cardiac surgery
New randomised trial ...
Study suggests alternatives to BMI for predicting risk of cardiovascular disease
The size of a person’...
SMARTFLOW trial of AI-powered coronary physiology assessment tool gets underway
AngioInsight has anno...
New data available on real-world performance of venous vascular closure system
Haemonetics Corporati...
AI-powered coronary inflammation quantification tool given US FDA de novo authorisation
Caristo Diagnostics has a...
BASKET BALL trial of sirolimus-coated balloon in complex coronary disease gets underway
B Braun has announced...
Coronary tissue engineered vessel to be studied in first-in-human trial
Humacyte has announced th...
Trial of siRNA therapy in coronary artery disease reports positive initial results
Positive results have bee...
Patient enrolment completed in trial of self-expanding dry-valve TAVI device
Venus Medtech has announc...
Presence of modifiable risk factors associated with greater coronary plaque burden
Having more modifiable ri...
ICECAP trial of localised cryotherapy treatment for coronary artery disease gets underway
CryoTherapeutics has anno...
Study to use AI-powered imaging software to chart coronary plaque progression
Elucid has announced ...
No difference in event rates for secondary access strategies during TAVI
Using a transradial appro...
ENHANCE early feasibility study of novel mitral repair system gets underway
Nyra Medical has anno...
IVL matches rotational atherectomy for plaque preparation in severely calcified lesions
Intravascular lithotr...
Registry data offer real-world comparison of Triclip against randomised trial performance
Early registry data s...
Investment supports expansion of CE mark trial of Thubrikar TAVI system
Thubrikar Aortic Valve ha...
CroíValve to expand study of Duo Adapt system following latest funding round
CroíValve has announc...
ViMech procedure offers new hope for treating patients with mechanical aortic valve failure
Fracturing the discs ...
First routine cases performed using ultrasound treatment for aortic stenosis
Cardiawave has announced ...
PARADIGM trial of DurAVR TAVI valve to begin enrolling at French centres
Anteris Technologies has ...
IPEC2 study sheds light on experiences of women with cardiovascular disease
Global Heart Hub has ...
Four-year data show “favourable” safety and performance of resorbable magnesium scaffold
Teleflex has announced th...
First patients enrolled in study of pulsatile IVL in coronary artery disease
Amplitude Vascular System...
Advertorial: Lifetime management in TAVI: How index valve selection impacts future outcomes
This advertorial is spons...
Advertorial: Extending the benefits of overhead arm positioning to more patients
This advertorial is spons...
SUBCUT HF II trial reports fewer hospital days for HF patients treated for oedema with novel therapy
SQ Innovation has ann...
First-in-human trial of next-generation robotic PCI system completes enrolment
Robocath has announce...
Abbott’s latest-generation Ultreon software gains FDA approval, CE mark
Abbott has received US Fo...
PlaqueTec secures funding to support development of intracoronary database
PlaqueTec, a medtech comp...
Study compares vascular closure systems in large-bore venous access closure procedures
Haemonetics Corporati...
Elucid launches lesion inspection tool for coronary and carotid plaque analysis
Elucid has announced ...
Protaryx Medical receives US FDA clearance for proprietary transseptal puncture device
Protaryx Medical has ...
Heart failure found to be common in people with AF detected during screening
Heart failure is common i...
New STORM-PE data show improved functional outcomes with CAVT plus anticoagulation
The 90-day results of...
Latest data from TRISCEND II trial look at crossover patients treated with Evoque system
Edwards Lifesciences ...
Electronic notifications “improve timely evaluation of structural heart disease”
Medtronic has released da...
SirPAD: Primary results confirm safety and efficacy of sirolimus-coated balloon in PAD
In the SirPAD trial, ...
Clinical trial finds comparable performance between TAVI embolic protection devices
Results from the PROT...
Performance of AI-powered physiologic assessment tool shows promise in ALL-RISE trial
An artificial intelli...
Evolocumab reduces risk of cardiac events in patients with no known atherosclerosis and diabetes
The cholesterol-lower...
First patient treated in USA with next-generation sutureless aortic valve
Corcym has announced the ...
Funding secured to accelerate study of mitral posterior leaflet management system
Polares Medical has close...
First patient treated in US trial of renal pelvic denervation technology
Verve Medical has announc...
THT 2026: HFrEF patients undergoing baroreflex activation therapy see shift in LVEF
Initial six-month outcome...
THT 2026: Study of smart implant for heart failure decongestion reports first-in-human data
Relief Cardiovascular...
Evolut Low Risk investigators probe increasing reintervention rate beyond six years
Latest data from the ...
US FDA approves CT angiography system for visualising cardiac conduction system
Cara Medical has anno...
EAPCI Summit: Serbian registry offers new insight on spontaneous coronary artery dissection
Stent implantation ma...
Symplicity Spyral renal denervation system gains reimbursement approval in Japan
Medtronic has announc...
EAPCI Summit: Rise in primary PCIs has not shifted the dial on acute MI mortality
An increase in the number...
EAPCI Summit: One in five patients can be discharged on day of TAVI procedure
Same-day hospital dischar...
PICCOLETO IV trial investigating SAPT after DCB-PCI in high-risk population launches
Investigators have an...
AI-based ECG technology may improve aortic stenosis mortality prediction
AccurKardia has announced...
First case of transcatheter mitral annuloplasty performed in AMEND EFS trial
The first procedure h...
Funding secured to advance clinical programme for implantable heart failure device
Berlin Heals has announce...
Statins likely not the cause of most side effects listed on packaging leaflets
A major review of adv...
STS data suggest surgeons have begun to shift the tide in TAVI explant mortality
Operative mortality f...
UK’s NICE recommends implantable device for remote heart failure monitoring
The UK’s National Ins...
STS 2026: Long-term comparison of multi-arterial CABG strategies finds similar survival rates
Two of the most commo...
Badhwar elected STS president with focus on “excellence, evidence and impact”
The Society of Thorac...
Robocath launches FIH clinical study of second-generation robotic system in coronary artery disease
Robocath has announce...
Study validates AI tool’s ability to detect valvular disease and ventricular dysfunction
AISAP has announced t...
Demonstrating the case for inpatient prehab and rehab for advanced heart failure
Frailty has become a ...
First-in-man VECTOR procedure offers new approach for preventing coronary obstruction
The first-in-man use ...
Societies urge action on environmental stressors contributing to cardiovascular disease deaths
Leading cardiovascular so...
Conavi Medical secures funds to advance next-generation intravascular imaging platform
Conavi Medical has comple...
Bypass surgery may offer longer-term benefit to women with severe coronary disease compared to PCI
Women with chronic se...
YorLabs’s intracardiac imaging system used for first time following US FDA clearance
YorLabs has announced the...
Non-invasive screening system “actively detects elevated LV end-diastolic pressure”
Ventric Health has an...
Delivery system for PDA closure in premature infants gains regulatory approvals
Abbott has received US Fo...
AI platform identifies “critical mass” threshold of non-obstructive plaque in coronary artery disease
Latest data from the inte...
Aquapass fluid overload management system gains marketing approval in Israel
Aquapass has received Isr...
EACVI: Study sheds light on prevalence of valvular heart disease amongst cancer patients
Valvular heart disease, i...
Analysis shows predictive value of FFR-CT for cardiovascular events in angina patients
Reduced coronary blood fl...
RoseDoc system gets first-in-human use in tricuspid valve replacement cases
Allmed Solutions has ...
Premarket notification submitted to FDA for SSi Mantra surgical robotic system
SS Innovations Intern...
Tenecteplase non-inferior to alteplase in thrombolytic success for valve thrombosis
Tenecteplase may be a saf...
“Durable” valve performance seen with early generation transapical TMVR system
Five-year results of ...
Largest dataset from ALIGN-AR trial shows favourable outcomes with Trilogy valve
Data from 700 patient...
RSNA 2025: Abdominal obesity associated with harmful changes in heart structure
A new study using adv...
“We need to look at the totality of evidence”: VIVA panellists examine SWEDEPAD findings
A focused session at ...
Advertorial: Trial of drug-eluting balloon technology “game-changing” for PCI in de novo coronary lesions
This advertorial is spons...
Vascular complications uncommon in study of latest-generation arterial closure device
No major vascular com...
CryoTherapeutics, SpectraWAVE and CRF partner for ICECAP clinical study
CryoTherapeutics has anno...
PCR London Valves 2025 hears latest data from LANDMARK trial of Myval TAVI device
Meril Life Sciences h...
Cost analysis suggests benefit of early TAVI in asymptomatic aortic stenosis
Edwards Lifesciences ...
Low rates of PPM seen following TAVI in small aortic annuli with DurAVR system
Thirty-day clinical o...
AHA 2025: PCKS9 inhibitor use reduced LDL levels after heart transplant surgery
The PCSK9 inhibitor a...
Native vessel PCI “no longer the default strategy” for patients with previous CABG
Should interventionalis...
Alteplase fails to impact outcomes in STEMI patients with high thrombus burden
Low-dose intracoronary ...
Tendyne system shows promise in patients with mitral annular calcification
A trial of transcathete...
Transseptal TMVR system shows promise in patients unsuited for surgery or TEER
Results of a pivotal cl...
Latest data “reassuring” on safety and effectiveness of transcatheter tricuspid interventions
Analysis of data from t...
Advertorial: No fear of dissection: How dissections can support positive outcomes in DCB therapy
This advertorial is spons...
TCT 2025: Coronary bioadaptor shows reduction in events compared to DES at two years
Latest clinical resul...
TCT 2025: TAVI continues to match up to surgery at seven years in PARTNER 3 trial
Latest results from t...
TCT 2025: “Site-less” trial opens window on prevalence of heart valve disease across USA
A “site-less” trial t...
TCT 2025: Trials find comparable outcomes for IVL alternatives in calcified coronary disease
Cutting balloon angio...
TCT 2025: Three-year results demonstrate “durable” impact of radiofrequency renal denervation
Medtronic has announc...
TCT 2025: Selution SLR meets non-inferiority in de novo and in-stent restenosis trials
Cordis has announced ...
Smart implant for pressure-guided heart failure decongestion wins TCT 2025 Shark Tank prize
Relief Cardiovascular...
Protaryx Medical submits premarket notification to US FDA for transseptal puncture device
Protaryx Medical has ...
Sustained remodelling achieved at two years with AccuCinch LV restoration system
Ancora Heart has anno...
First-in-human study of Cardiac Leaflet Enhancer reaches enrolment milestone
Nyra Medical has anno...
Medtronic partners with DASI Simulations to bring AI modelling technology to US TAVI centres
Medtronic and DASI Simula...
AI algorithm for MAC detection and quantification gains US FDA approval
Bunkerhill Health has rec...
Intensive cholesterol lowering fails to shift the dial on vein graft failure
Intensive LDL cholest...
Pivotal trial of tricuspid annuloplasty system to commence following IDE approval
Micro Interventional Devi...
Up to half of patients may experience AF after coronary surgery, but burden is low
A prospective study i...
“Abbey Bear” seeks to demystify LVAD treatment for young heart failure patients
Abbott has unveiled a...
US FDA approves IDE for investigation of FLOWer embolic protection device
AorticLab has announced t...
Taho Pharma submits new drug application to US FDA for apixaban oral dissolving film
Taho Pharmaceuticals has ...
Medtech Insights: Edwards’ Brüls outlines company’s move to specialise on structural heart disease
When Cardiovascular N...
DEEPER CORONARY study of Spur Elute retrievable scaffold system completes enrolment
Reflow Medical has announ...
Hearflow’s next-generation Plaque Analysis algorithm gains US FDA clearance
Heartflow has receive...
BioCardia announces top line data from trial of CardiaAMP cell therapy procedure
BioCardia has announc...
SCAI initiative seeks to establish faster diagnosis of cardiogenic shock
A new initiative by the S...
New preclinical data show early patency of coronary tissue engineered vessel
Humacyte has announced th...
SYMPHONY-PE trial demonstrates positive efficacy, efficiency, and safety results
Imperative Care has annou...
J-Valve TAVI system granted approval for treatment of aortic regurgitation in China
Genesis MedTech's structu...
CORE-MD consortium announces recommendations on clinical assessment of high-risk medical devices
The CORE-MD—Coordinating ...
Neurescue device receives CE mark for treating non-shockable cardiac arrest
Neurescue has announced C...
First implantations of RoseDoc tricuspid valve replacement system begin in India
The first stage of th...
Laza Medical announces milestone in use of its AI-based heart model for ultrasound-guided procedures
Laza Medical has anno...
Imperative Care receives FDA 150k clearance for Symphony thrombectomy system
Imperative Care has a...
Symplicity Spyral renal denervation system gains Japanese PDMA approval
Medtronic has announced i...
ESC 2025: Studies shed new light on antiplatelet therapy after CABG surgery
New evidence offers f...
ESC 2025: Baxdrostat shows promise in lowering blood pressure in uncontrolled and resistant hypertension
Results from the BaxHTN ...
ESC 2025: REBOOT prompts rethink on use of beta blockers in uncomplicated MI
Beta-blocker therapy appe...
ESC 2025: Trial results add digitoxin as an option for patients with advanced heart failure
Digitoxin reduced the...
Advertorial: Expanded indications for Prevail DCB broaden options for complex PCI, including bifurcations
This advertorial is spons...
Favourable blood pressure and haemodynamic effects seen with AVIM therapy
Orchestra BioMed has anno...
Paradise ultrasound renal denervation system gets approved for use in Japan
Recor Medical has ann...
Agent DCB to be studied in de novo coronary trial including bifurcations and long lesions
Boston Scientific has ini...
Image-guided crossing and re-entry system used for first time in coronary CTO trial
Simpson Interventions has...
Heartflow raises more than US$364 million through initial public offering
Heartflow, a developer of...
Reprieve Cardiovascular announces funding and trial enrolment milestones
Reprieve Cardiovascular h...
Gentuity and GE HealthCare collaborate to improve availability of imaging systems
Gentuity has announced an...
Wearable patch may speed up diagnosis of atrial fibrillation after cardiac surgery
The use of a wearable ele...
Japanese registry data support TEER in atrial functional mitral regurgitation patients
Patients with atrial func...
ShortCut leaflet splitting device granted add-on payment designation by CMS
Pi-Cardia has announc...
First patients enrolled in MAGICAL-SV study of sirolimus DCB in small coronary vessels
Concept Medical has annou...
SRS 2025: Intercontinental robotic cardiac surgery completed using SSi Mantra 3 system
SS Innovations Intern...
Trial shows potential of low-level microcurrent stimulation in heart failure
Results of the C-MIC ...
First patient enrolled in continued access protocol trial of heart transplant technology
Xvivo has announced that ...
Preliminary data “encouraging” for biorestorative coronary bypass conduit
Xeltis has announced prel...
US FDA gives approval to commercialise AI software to guide transcatheter procedures
Caranx Medical has an...
Trial comparing TAVI and SAVR in aortic regurgitation enrols first patients
JenaValve has announced t...
First patient treated in trial of multi-organ denervation for uncontrolled hypertension
Medtronic has announced t...
EARLY TAVR: Analysis looks at trial’s outcomes based on guideline recommendations
New analysis of the EARLY...
First procedures performed in FRACTURE trial of Bolt IVL system in coronary artery disease
The first US procedur...
First patient enrolled in EASE HF2 study of Intershunt technology for HFrEF treatment
InterShunt Technologies h...
Improved survival seen following TAVI explant compared to redo procedures
Analysis of real-world US...
SEISMIC-HF I study assesses use of non-invasive HFrEF management technology
Cardiosense has annou...
Vivasure Medical submits premarket approval for PerQseal Elite vascular closure device
Vivasure Medical has ...
First patient enrolled in RECOVER-AV trial of AlphaVac F18 system for treatment of acute PE
AngioDynamics has announc...
ADA 2025: Semaglutide taken orally shown to reduce cardiovascular risk in type 2 diabetes patients
Research presented at the...
Study intensifies call for randomised trial in patients with bicuspid aortic stenosis
The results of a retr...
Stroke rates diverge among TAVI and surgery patients at five years in pragmatic trial
Long-term results of ...
Ceryx Medical to develop physiologically responsive pacemaker following funding boost
Ceryx Medical has announc...
Prevencio granted patents to protect proprietary coronary artery disease blood test platform
Prevencio has been grante...
Enrolment completed in ATHENS-HF first-in-human study of Adona interatrial atrial shunt
Adona Medical has ann...
Funding round allows completion of RESPONDER-HF trial of Corvia atrial shunt
Corvia Medical has an...
EMPACT-MI analysis “reassuring” on use of empagliflozin in patients with poor kidney function
Empagliflozin preserv...
EuroPCR 2025: Thirty-day results show promise for Lux-Valve Plus TTVR system
Jenscare has announce...
Surgical ablation during CABG carries survival advantage for patients with preexisting AF
Medicare patients with at...
EuroPCR 2025: Myval shows promise in latest comparative studies against contemporary TAVI platforms
New data comparing th...
EuroPCR 2025: Three-year data available for Freesolve resorbable magnesium scaffold
Thirty-six-month follow-u...
EuroPCR 2025: Sustained reduction in TR seen at two years with Triclip in real-world data
Two-year outcomes fro...
Tackling unacceptable mortality in aortic stenosis: A call to expand TAVI access
Transcatheter aortic valv...
EuroPCR 2025: Search for suitable candidates for cerebral embolic protection continues
A pooled, individual pati...
EuroPCR 2025: All-female coronary IVL trial reports positive outcomes at 30 days
Thirty-day primary en...
“Urgent need” to move away from lead in mitigating cath lab radiation exposure
With an increasing fo...
Advertorial: New data underline the importance of lifetime management of aortic stenosis patients
This advertorial is spons...
Early analysis of BIOPATTERN trial offers insights on make-up of coronary plaque
PlaqueTec has announced n...
FastWave Medical to commence coronary feasibility study of laser IVL system
FastWave Medical has secu...
SCAI 2025: Early TAVI “should be preferred to clinical surveillance in all age groups”
Analysis from the EARLY T...
SCAI 2025: Stenting “improves long-term survival” for patients undergoing CTO PCI
In patients undergoing ch...
CX 2025: Managing blood pressure with medical therapy may play a role in limiting AAA growth
Results from the Cent...
Edwards’ Sapien 3 lands US FDA approval for the treatment of asymptomatic severe AS
Edwards Lifesciences ...
STS launches risk calculator for ascending aorta and aortic root surgery
The Society of Thoracic S...
Atrioventricular interval modulation therapy granted US FDA breakthrough designation
Orchestra BioMed Holdings...
Eight-year data “encouraging” for aortic valves using Resilia tissue technology
Edwards Lifesciences has ...
Edward Lifesciences’ Sapien M3 transfemoral mitral valve system gains CE mark
Edwards Lifesciences ...
Trial results open door to frozen plasma alternative for bleeding management in cardiac surgery
Four-factor prothromb...
“Sustained” clinical benefits seen at six months in Altavalve early feasibility study
Results of the Altava...
US FDA clears phase 3 clinical study of ASI-02 in patients undergoing TTE
The US Food and Drug Admi...
Shockwave commences trial of Javelin IVL catheter in complex coronary disease
Shockwave Medical, pa...
ACC.25: Low-dose colchicine seen to reduce coronary plaque progression in EKSTROM trial
Low-dose colchicine (0.5m...
Lancet Commission urges reframing of coronary disease towards atherosclerosis
Experts in the treatm...
Teleflex announces US FDA clearance for AC3 Range intra-aortic balloon pump
Teleflex has announced US...
ACC.25: ALIGN-AR reports positive outcomes with dedicated TAVI device for aortic regurgitation
Data from 500 patient...
ACC.25: Cerebral embolic protection found not to reduce stroke in BHF PROTECT TAVI trial
Use of cerebral embol...
ACC.25: Bentracimab can reverse bleeding complications linked to ticagrelor
An investigational mo...
Preliminary IDE trial results demonstrate efficacy of dedicated device for coronary perforations
Teleflex has announced th...
CRT 2025: New TAV-in-SAV data underline importance of aortic valve sizing at index procedure
New data on the outco...
New funding to support expansion of clinical programme for Supira Medical pVAD
Supira Medical has announ...
PMcardio STEMI AI ECG tool earns US FDA breakthrough device designation
Powerful Medical has been...
CRT 2025: First-in-human cases using robotic-assisted TMVR system performed in Chile
Details of the succes...
GE HealthCare launches AltiX AI.i editions of its Mac-Lab, CardioLab and ComboLab systems
GE HealthCare has announc...
SMARTFLOW study to assess diagnostic accuracy of AI-powered angiography image interpretation software
AngioInsight has announce...
CRT 2025: AGENT IDE trial results “consistent” out to two years using DCB in ISR
Consistent results ha...
Research project seeks to update cardiovascular risk calculations using latest technology
Robert Wood Johnson U...
Valcare Medical receives US FDA approval to initiate EFS for Amend transseptal system
Valcare Medical has a...
Global Cardiovascular Awards – The full list of winners and highly commended entries
Best Cardiovascular...
Innovation and excellence celebrated at second Global Cardiovascular Awards
One of interventional car...
CRT 2025: Improved haemodynamics seen with supra-annular TAVI system at two years in SMART trial
Two-year results of t...
CRT 2025: SCAAR analysis shows comparable outcomes between Prevail and other DCBs
A real-world study of...
Boston Scientific among investors in latest financing round for 4C Medical Technologies
4C Medical Technologies h...
Stereotaxis seeks to broaden use of its robotic magnetic navigation system into multiple endovascular fields
Stereotaxis has announced...
DeepQure advances clinical trials of its HyperQure extravascular renal denervation system
DeepQure has announce...
Boston Scientific to acquire renal denervation technology developer SoniVie
Boston Scientific has...
First US commercial cases performed with ShortCut leaflet modification device
Pi-Cardia has announc...
Pulnovo Medical closes series C financing round in support of two US FDA trials
Pulnovo Medical has annou...
Biotronik partners with Egg Medical to bring radiation protection systems to US healthcare workers
Biotronik is partnering w...
Medtronic commences Prevail Global study as it seeks coronary DCB approvals in USA and Japan
Medtronic has announced t...
Advertorial: DCB Days showcases new momentum in drug-coated balloon PCI
This advertorial is spons...
Biotronik’s Freesolve resorbable scaffold to be studied in long lesions
Biotronik has announced t...
Challenges of 21st century aortic education, innovation and evidence get top billing at CX 2025
Critical challenges i...
Economic analysis supports cost-effectiveness of Guardian monitoring system in high-risk acute coronary syndromes
Avertix Medical has annou...
THT 2025: eLym system “promising” for treatment of fluid overload in ADHF patients
WhiteSwell has announced ...
American Society of Echocardiography releases new guideline on ultrasound-guided vascular access
A new guideline from the ...
THT 2025: Reprieve system meets endpoints in FASTR randomised pilot study
Reprieve Cardiovascular h...
Coronary CT angiography-guided management of stable chest pains shows benefit out to 10 years
Coronary computed tom...
Heart teams digest role of early aortic intervention following EARLY TAVR and EVOLVED trials
Two trials delivered in l...
Data and device tweaks herald ‘practice-changing’ future for bioabsorbable scaffolds
Pending the results o...
EACTS launches grant scheme for heart valve care in underserved regions
A new outreach programme ...
STS 2025: Mechanical aortic valves “confer a significant survival advantage” in patients under 60
Mechanical aortic val...
Atraverse announces clinical evidence validating Hotwire radiofrequency guidewire system
Clinical evidence sup...
First commercial cases using CrossFAST advanced delivery system performed in USA
Vantis Vascular has annou...
Factor XI inhibitor ‘lives up to promise’ of reduced bleeding events in AF patients
Researchers from Mass Gen...
Humacyte files for investigational use of tissue engineered vessel in CABG
Humacyte has announced th...
Cardiac surgery societies endorse ESC coronary revascularisation recommendations
Four cardiac surgery soci...
Alleviant Medical secures funding for second pivotal trial of no-implant atrial shunt
Alleviant Medical has ann...
Biotronik nets short DAPT and calcified lesion indications for Orsiro Mission DES
Biotronik has announced C...
CoreMedic and InnoRa partner to accelerate development of ChordArt mitral repair system
CoreMedic has entered int...
AVENTUS trial of thrombectomy system for PE treatment completes enrolment
Inquis Medical has announ...
First patients treated in TRICURE EFS study of Topaz tricuspid heart valve replacement system
TRiCares has announce...
Relief Cardiovascular closes financing round to fund first-in-human study
Relief Cardiovascular has...
Study finds adverse outcomes after decreased use of paclitaxel-coated devices
A recent analysis of ...
Alleviant Medical to commence pivotal trial of no-implant atrial shunt in HFrEF patients
Alleviant Medical has ann...
Enrolment completed in ALL-RISE trial of FFRangio coronary physiology assessment
CathWorks has announc...
First-in-human results “demonstrate potential of Reprieve system” in ADHF treatment
Reprieve Cardiovascular h...
First-in-human study of Protaryx transseptal puncture technology completed
Protaryx Medical has anno...
Robotic aortic valve replacement offers an “exciting new chapter” in the treatment of aortic valve disease
The rapid growth of trans...
PCR London Valves 2024: Live cases at cardiology conferences “do not compromise patient safety”
Live cases broadcast ...
PERIGON trial demonstrates durability of Avalus aortic valve at seven years
Seven-year results of...
PCR London Valves 2024: New data presented alongside launch of latest-generation Myval device
New analysis of the M...
WVU team performs pioneering combined robotic aortic valve replacement and coronary bypass procedure
The multidisciplinary...
Scottish centres adopt on-screen system for endoscopic vessel harvesting
A Glasgow-based company h...
ACURATE IDE results put spotlight on impact of valve under-expansion after TAVI
“Disappointed is an u...
First patient procedures performed with Abbott’s balloon-expandable TAVI system
Abbott has announced ...
EACTS past president puts innovation and inclusivity at the top of the agenda
The immediate past pr...
AHA 2024: Five-year Amulet IDE data show similar outcomes with Amplatzer and Watchman devices
Latest data from the ...
AHA 2024: OPTION trial reports positive outcomes for Watchman FLX at three years after AF ablation
Three-year results fr...
AHA 2024: Edoxaban an “effective alternative” to warfarin following valve replacement surgery
Edoxaban may be an effect...
Advertorial: Newest-generation TAVI platforms designed to meet the demands of the modern cath lab
This advertorial is spons...
BrightHeart gains US FDA clearance for AI ultrasound software for detecting congenital heart defects
BrightHeart has received ...
What they don’t teach in fellowship: Business insights for young cardiologists
Interventional cardio...
Trilogy valve shows favourable results at two years in aortic regurgitation patients
Latest data from the ...
CONFIRM-2 registry demonstrates use of AI-enabled quantitative CT for predicting MACE
Late-breaking study r...
Initial results of Sikelia transcatheter heart valve shared at TCT 2024
MitrAssist Lifesciences h...
First patient enrolled in study of integrated laser atherectomy and IVL catheter
Royal Philips has announc...
TCT 2024 hears one-year results of TRAVEL II study of transcatheter tricuspid replacement system
One-year outcomes of ...
TCT 2024: Six-month data reflect safety and efficacy of Lithix HC-IVL system
Six-month data from t...
TCT 2024: TRISCEND II reports positive outcomes for tricuspid replacement system
The Evoque (Edwards L...
TCT 2024: Two-year SPYRAL HTN-ON MED show “consistent” effect of renal denervation
Medtronic has announc...
TCT 2024: New evidence could prompt rethink over use of colchicine following acute MI
The largest trial to ...
TCT 2024: PATCH study reports initial positive results for sutureless vascular closure system
Vivasure Medical has ...
TCT 2024: Non-invasive ultrasound therapy device shows promise in calcific aortic stenosis
The Valvosoft non-invasiv...
TCT 2024: Coronary bioadaptor shows clinical benefit in complex PCI sub-groups
Late-breaking data fr...
TCT 2024: EARLY TAVR shows early intervention may be fruitful in asymptomatic aortic stenosis
EARLY TAVR lived up t...
TCT 2024: TAVI does not shift the dial in heart failure patients with moderate aortic stenosis
Transcatheter aortic ...
TCT 2024: Adjustable valve replacement system wins Shark Tank innovation prize
Symbiosis, the develo...
First US cases performed with Vertex PE system in SPIRARE II pivotal study
Jupiter Endovascular has ...
Medtronic receives US FDA approval of Affera mapping and ablation system and Sphere-9 catheter
Medtronic has announc...
First patients treated with Duo tricuspid coaptation system in TANDEM II study
CroíValve has announced t...
COVID-19 infection may increase risk of heart attack up to three years later
An analysis of data in th...
Study highlights mortality disparity among minority patients undergoing CABG
Black patients are 22% mo...
EACTS 2024: Robotic aortic valve replacement shows promise as an alternative to TAVI
Robotic aortic valve ...
Kaminari Medical closes €3.8 million financing round to advance intravascular imaging system
Kaminari Medical has ...
EACTS 2024: Digital “prehabilitation” programme reduces adverse events after cardiac surgery
Patients awaiting car...
AI-based aortic stenosis screening software gains US FDA breakthrough designation
AccurKardia has announced...
Advertorial: Stent overexpansion is key to overcoming variable diameter in complex PCI cases
This advertorial is spons...
HFSA 2024: Aficamten shows improvement in clinical markers used to inform HCM care
Cytokinetics has announce...
US FDA approves Flyrcado injection PET radiotracer for diagnosis of coronary artery disease
GE HealthCare has announc...
UK societies call for concerted effort to tackle cardiovascular disease in women
Concerted efforts are...
SSCORE registry of super saturated oxygen therapy in LAD STEMI patients begins
Zoll has announced that t...
Latest TRILUMINATE and TRI.Fr data add to growing body of evidence for tricuspid TEER
Data continue to emer...
PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease
PlaqueTec and RxCelerate ...
No-touch graft harvesting technique shows “no benefit, but significant harm” in SWEDEGRAFT study
A multicentre, regist...
SpectraWAVE eyes commercial expansion of its HypreVUE intravascular imaging system
SpectraWAVE has annou...
Advertorial: DCB may be an appealing strategy in diabetic patients undergoing PCI
This advertorial is spons...
First two TAVI procedures completed using Venus-Vitae valve in SMART ALIGN trial
Venus Medtech has ann...
ESC 2024: New evidence suggests fasting not needed before cardiac catheterisation procedures
A randomised trial testin...
ESC 2024: Invasive strategy does not reduce risk of cardiovascular death or non-fatal MI in older NSTEMI patients
A trial comparing an inva...
ESC 2024: TAVI “superior” to surgery in women with severe aortic stenosis
The first trial comparing...
ESC 2024: RESHAPE-HF2 results move conversation forward on effectiveness of TEER in functional MR
A strategy of mitral tran...
ESC hypertension guidelines stipulate conditions for renal denervation use
ESC guidelines on the man...
ESC 2024: Remote echocardiograms offer “relatively good diagnostic accuracy”
Research presented at...
Nanox receives FDA approval for its latest generation AI platform for coronary disease detection
Nano X Imaging has announ...
Survey highlights complication rates among pregnant cardiology trainees
A survey among female car...
AI models have potential in heart team decision-making, but beware blindspots
Large language models...
BioCardia submits 510(k) approval for Morph DNA steerable introducer sheath family
BioCardia has submitted a...
NMPA approves SyMap renal denervation system for treatment of uncontrolled hypertension
China’s National Medical ...
Funding allows CroíValve to advance US early feasibility study of Duo tricuspid valve
CroíValve has closed a US...
Trialists call for rethink over use of MACE as a primary endpoint in cardiovascular trials
Three noted cardiovas...
Research aims to understand training needs for left-handed cardiac surgeons
For the estimated one in ...
Diabetic PCI patients have a higher risk of stent failure without glycaemic control
An observational stud...
Texas Heart Institute performs first-in-human implantation of BiVACOR total artificial heart
The Texas Heart Insti...
First patients treated in US GPS study of Paradise renal denervation system
The first patients in...
Edwards Lifesciences continues acquisition spree, announcing JenaValve and Endotronix deals
Edwards Lifesciences has ...
Prevencio receives US patent for AI-powered test of obstructive coronary artery disease
Prevencio has been issued...
Latest round of funding secured to boost clinical programmes for Topaz tricuspid valve system
TRiCares SAS has anno...
ContraBand pulmonary artery banding system gains US FDA breakthrough status for HFrEF treatment
Restore Medical has been ...
Consumer wearables found to have clinical value in assessing treatment for AF and heart failure
Monitoring of heart rate ...
Health Canada grants approval for use of Pascal Precision to reduce significant, symptomatic MR
Edwards Lifesciences has ...
TruLeaf Medical to commence clinical trial of RoseDoc two-stage TMVR system
TruLeaf Medical has r...
Adona Medical secures financing to initiate clinical use of interatrial shunt device
Adona Medical has sec...
Medtech Insights: Trial pipeline underpins growth strategy for Watchman LAAC device
Investment in a programme...
Orsiro Mission DES available in expanded maximum allowed diameters range
Biotronik has announced t...
Anteris Technologies and v2vmedtech reach concept lock on VClip TEER system
Anteris Technologies and ...
DEEPER CORONARY trial of Spur system for coronary in-stent restenosis gets underway
Reflow Medical has announ...
First patients enrolled in study of pulmonary artery denervation treatment
Pulnovo Medical Limited h...
FASTIII trial of angiography-based vessel fractional flow reserve completes enrolment
Pie Medical Imaging has a...
DynamX sirolimus-eluting bioadaptor system gains US FDA breakthrough designation
Elixir Medical has an...
Abbott receives CE mark for Aveir dual chamber leadless pacemaker system
Abbott has received CE ma...
First-in-human results with Mirus Siegel TAVI valve presented at New York Valves 2024
Initial experience wi...
Investigators find small reduction in disabling stroke from embolic protection device use
Analysis of data from...
New York Valves hears five-year data from PARTNER trials focused on small annulus patients
Results of an analysi...
Edwards Lifesciences to strengthen structural heart business after sale of Critical Care group
Edwards Lifesciences has ...
HighLife to initiate US pivotal study of transseptal mitral valve replacement system
HighLife SAS has announce...
Terumo Cardiovascular gains US FDA clearance for CDI OneView monitoring system
Terumo Cardiovascular...
US FDA gives breakthrough device designation for lipoprotein blood test
Roche has announced that ...
GE Healthcare and Medis Medical collaborate to commercialise QFR technology
GE HealthCare and Med...
Anteris Technologies reports successful deployment of DurAVR in challenging valve-in-valve case
Anteris Technologies has ...
EuroPCR 2024: SMART trial data offer new insight on TAVI device choice in women
Data from the SMART t...
First patient enrolled in BIOMAG-II trial of Freesolve resorbable scaffold
Biotronik has announced t...
Global Heart Hub shares findings from the Patients living with Elevated Cholesterol data programme
Global Heart Hub, an inte...
IVUS-guided PCI comes out on top over angiography in trial in acute coronary syndrome patients
In patients with acut...
Medtech Insights: Transcatheter tricuspid therapies “on the cusp of becoming standard of care”
The advance of transc...
Advertorial: Handheld ultrasound: Providing a window into patients’ hearts at the point of care
This advertorial is spons...
Two-year echocardiographic data from REDUCE LAP-HF II trial published in JAMA Cardiology
Corvia Medical has an...
Advertorial: TAVI in small aortic annuli: SMART trial underscores importance of choosing the right device
This advertorial is spons...
PCI for stable coronary artery disease can be performed safely before, during or after TAVI
Percutaneous coronary int...
Abbott’s Esprit BTK scaffold system given US FDA approval for CLTI treatment
Abbott has announced that...
STS updates risk calculators for tricuspid surgery, CABG and SAVR after TAVI
The Society of Thoracic S...
Acolyte system for guidewire positioning and placement in CTOs given US FDA breakthrough device status
Simpson Interventions has...
Caranx Medical announces successful robotic TAVI procedure in an animal
Caranx Medical has announ...
First large bore venous patient treated with PerQseal Elite vascular closure system
Vivasure Medical has anno...
Transverse Medical restructures board as it seeks to bring cerebral embolic protection system to market
Transverse Medical, devel...
ACC 2024: Use of Impella CP may boost survival in STEMI patients with cardiogenic shock
Use of the Impella CP...
Survey highlights lack of awareness of among women of heart valve disease and risk factors
Medtronic has unveile...
ACC 2024: Interatrial shunt fails to meet primary endpoint in RELIEVE-HF trial
Patients with heart f...
ACC 2024: AEDs used in a small number of cardiac arrest cases, despite proximity
Automated external de...
One in 10 deaths after PCI found to be “preventable”, US state-wide analysis suggests
Around 10% of all deaths ...
AI software integrated into GE Healthcare’s Vscan Air SL handheld ultrasound imaging system
GE HealthCare has ann...
Leadership change at TRiCares sees Atricure and Medtronic veteran join as president and CEO
TRiCares has announce...
PROTEMBO randomised trial of three-vessel cerebral embolic protection device enrols first patient
Protembis has announced t...
Winrevair given US FDA approval for the treatment of pulmonary arterial hypertension
Merck has announced the U...
Cardiac surgeon and interventional cardiologist join egnite’s medical advisory board
egnite, a digital health ...
US registry launches to evaluate physician decision-making using HeartFlow Plaque Analysis
HeartFlow has announced t...
ENVISION trial of Abbott’s Navitor TAVI valve in low-risk patients enrols first patient
Abbott has announced that...
CRT 2024: Shield system cuts operator exposure to radiation during cath lab procedures
The use of a radiatio...
CRT 2024: US DCB approval provides “important treatment option” for in-stent restenosis
The first US Food and...
Robotic system “brings transcervical aortic valve replacement a step closer”
A company specialising in...
Health Canada licenses Symplicity Spyral radiofrequency renal denervation system to treat hypertension
Medtronic has received a ...
Funding round closes in support of ConKay annuloplasty system for TR treatment
ConKay Medical Systems, a...
Global Cardiovascular Awards – The full list of winners and highly commended entries
Best Cardiovascular...
Past, present and future of cardiovascular innovation celebrated at Global Cardiovascular Awards
A founding father of ...
Cost-effectiveness and updated efficacy data from Evolut Low Risk trial shared at CRT 2024
Medtronic has announc...
ADVERTORIAL: TAVI offers promise in the “underdiagnosed and undertreated” aortic regurgitation population
This advertorial is spons...
First mitral valve replacement performed using SSi Mantra robotic system
SS Innovations Internatio...
CRT 2024: SAFE-MCS finds reduction in bleeding for high-risk PCI patients with bleed monitoring system
Saranas has announced res...
Cleerly receives US FDA breakthrough designation for CAD staging system
Cleerly has been granted ...
PROACTIVE-HF pivotal trial of Cordella pulmonary artery sensor meets primary endpoints
Six-month results fro...
Trial of autologous cell therapy in advanced chronic heart failure reports interim results at THT 2024
BioCardia has announced i...
Patient enrolment completed in study of remote heart failure monitoring device
FIRE1 today announced tha...
First patient treated using A-Flux Reducer interventional system for angina
VahatiCor has announc...
Challenges establishing minimally invasive cardiac surgery in the developing world
Attaulah Khan Niazi (King...
Analyses provide “hard evidence” of benefit of intravascular imaging-guided PCI
Two meta-analyses com...
Australian government offers grant support to artificial heart programme
BiVACOR, a clinical-stage...
Study of TIVUS renal denervation system for hypertension treatment completes enrolment
The REDUCED-1 study, a US...
Health Canada approves VenusP-Valve transcatheter pulmonic valve replacement system
Venus Medtech has announc...
Early feasibility study of TAVI platform for treatment of aortic regurgitation completes enrolment
Genesis MedTech has annou...
Evoque becomes first transcatheter tricuspid system to gain US FDA approval
Edwards Lifesciences ...
AF Symposium 2024: AI-enabled predictive pre-planning “significantly improves LAAO procedural efficiency”
Data from the first US co...
STS 2024: Data show shift in the proportion of patients under 60 receiving TAVI instead of SAVR
Research presented at...
French registry study finds fewer cardiovascular deaths among mitral regurgitation patients receiving TEER
The results of a propensi...
Early feasibility study of CroíValve’s Duo tricuspid coaptation valve system launches
CroíValve has announced t...
Collaboration aims to develop a bespoke cell phenotyping assay for human blood
PlaqueTec, a company iden...
Three valve-in-valve procedures completed using DurAVR transcatheter valve
Anteris Technologies has ...
US FDA grants breakthrough designation for Pi-Cardia’s ShortCut leaflet splitting device
Pi-Cardia has received br...
Radiofrequency renal denervation meets cost efficiency threshold in value analysis
An analysis of data f...
FastWave Medical announces completion of first procedures in study of novel peripheral IVL system
FastWave Medical has ...
Study shows no safety risk in allowing patients to eat prior to cardiac catherisation
Allowing patients to eat ...
“Structural heart leader” joins Cardiac Dimensions as chief medical officer
Cardiac Dimensions, a...
Penumbra launches Indigo system CAT RX catheter in Europe to treat acute coronary syndrome
Penumbra has secured CE m...
US FDA grants clearance for VR surgical planning software from Realize Medical
Realize Medical has annou...
First patient randomised in BACKBEAT study of AVIM therapy for uncontrolled hypertension
Orchestra BioMed Holdings...
Endotronix submits premarket approval application to US FDA for Cordella pulmonary artery sensor
Endotronix has submit...
Edwards Lifesciences appoints its first US case observation site under Benchmark TAVI programme
Eisenhower Health (Ra...
Topaz tricuspid valve replacement system used for the first time in a patient with a pacemaker
TRiCares SAS has announce...
Chilean centre treats five aortic regurgitation patients in a single day with Zeta TAVI system
Laguna Tech USA has annou...
Pulse Biosciences files premarket US FDA 510(k) notification for its CellFX nsPFA cardiac clamp
Pulse Biosciences has fil...
Investors offer backing for developer of transcatheter mitral chord repair technology
Norway-based CardioMe...
Blood potassium monitor under development to benefit patients with chronic renal failure
CardioRenal and CHU Greno...
Microbot Medical and Corewell Health announce telerobotics collaboration
Microbot Medical, develop...
Early use of mechanical support shows benefit for patients with AMI complicated by cardiogenic shock
Results of the National C...
First-in-man cross-country robotic coronary angioplasty performed in two Chinese centres
Robocath has announced a ...
Consortium to assess use of CT to improve diagnosis and treatment of coronary artery disease
A public-private partners...
Projected rise in aortic valve-in-valve procedures prompts interest in leaflet splitting device
Details of the first ...
Catheter Precision’s VIVO 3D mapping system secures reimbursement in NHS England’s SSDP
Healthcare 21 (HC21) has ...
Medtronic launches Penditure left atrial appendage exclusion system in the USA
Medtronic has announc...
First patients join pivotal trial of Aortix pump for treatment of acute decompensated heart failure
Procyrion has announc...
Bivacor gets US FDA nod for early feasibility of its total artificial heart
The US Food and Drug Admi...
BIOPATTERN trial seeks precision approach to coronary artery disease treatment
PlaqueTec has receive...
First patient enrolled in RECOVER IV randomised trial of Impella in AMI patients
Abiomed has announced tha...
AF after mitral valve surgery “has a strong negative influence on survival”
The occurrence of atrial ...
AI-derived risk score may improve planning of TEER for secondary mitral regurgitation
A novel risk score de...
SCAI: First US renal denervation approvals “revolutionise” treatment of uncontrolled hypertension
The approval of two renal...
Roadmap launched to guide shared decision-making in heart valve disease treatment
Global Heart Hub, an inte...
Medtronic’s Symplicity Spyral renal denervation system granted US FDA approval for hypertension treatment
Medtronic has announced a...
JenaValve partners with American Society of Echocardiography to increase awareness of aortic regurgitation
JenaValve Technology has ...
ADVERTORIAL: NOTION trial results crystallise long-term thinking on TAVI versus SAVR
This advertorial is spons...
ARIES trial shows LVAD patients who did not receive aspirin had fewer bleeding complications
Abbott has announced ...
ACCESS-MANTA registry to assess use of Manta vascular closure device in TAVI procedures
Teleflex has announced th...
TRANSFORM trial to explore personalised strategy for cardiovascular disease prevention
Cleerly has announced...
VOYAGER PAD analyses shed light on use of rivaroxaban in high-risk patient populations
New analyses from the...
PATCH clinical study of PerQseal vascular closure system reaches 100-patient milestone
Vivasure Medical has ...
First-in-human results of non-invasive ultrasound therapy for aortic stenosis published in The Lancet
Results from first-in-hum...
SELECT trial shows cardiovascular risk reduction in non-diabetics taking semaglutide
Results of the SELECT cli...
Medinbox launches latest proctoring and remote learning platform for cath labs
Medinbox has launched...
No difference in outcomes for AF patients undergoing LAAO and TAVI at the same time
Patients with atrial ...
E2 shares positive initial results from use of Hēlo system for acute sub-massive pulmonary embolism treatment
Endovascular Engineering ...
First patients enrolled in coronary de novo trial of Selution SLR drug-eluting balloon
Cordis has announced enro...
TCT 2023: TAVI system for aortic regurgitation shows promise in ALIGN AR trial
Positive results from...
Edwards Lifesciences’ Mitris Resilia valve receives CE mark for mitral replacement surgeries
Edwards Lifesciences has ...
TCT 2023: Intellistent multi-lumen stent system for pulmonary arterial hypertension wins Shark Tank innovation prize
HeartPoint Global was nam...
RELIEF clinical study of PFO closure for migraine relief begins randomisation
Patients have passed ...
Medtronic receives CE mark for Evolut FX TAVI system to treat severe aortic stenosis
Medtronic has received CE...
US FDA grants IDE approval for PROACTIVE-HF 2 study of Cordella pulmonary artery sensor
Endotronix has receiv...
EACTS 2023: On-X aortic valve “remains safe and effective with low dose warfarin”
Data from the On-X ao...
